ArticleJournal of clinical medicine2022

Serum Nardilysin as a Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma.

Yongfeng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.